XTL Biopharmaceuticals Ltd. (XTLB) NASDAQ

1.21

-0.0364(-2.92%)

Updated at September 08 02:49PM

Currency In USD

Valuation

Market Cap13.66M
Enterprise Value13.43M
P/E Ratio-8.28
PEG Ratio-1.33
Price/Sales Ratio24.71
Price/Book Ratio1.57
Enterprise/Revenue24.19
Enterprise/EBITDA-11.44

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-2.28
Operating Margin-4.82

Management Effectiveness

Return On Assets-0.12
Return On Equity-0.26

Income Statement

Revenue451,000
Revenue/Share0
Gross Profit3,000
EBITDA-930,000
Net Income-1.03M
Diluted EPS-0.15

Balance Sheet

Total Cash1.14M
Total Cash/Share0
Total Debt138,000
Total Debt/Equity0.03
Current Ratio0.61
Book Value Per Share0.01

Price History

52-Week Change-54.68
52-Week High2.7
52-Week Low0.86
Moving Average 50 Days1.42
Moving Average 200 Days1.45

Statistics

Average Volume37,414
Shares Outstanding5.45M
% Held by Institutions0.03

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:5
Last Split DateFebruary 10, 2017